Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.55
-0.23 (-2.96%)
Dec 5, 2025, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 258 | 174 | 303 | 252 | 114 | 192 | |
| Market Cap Growth | 132.93% | -42.68% | 20.14% | 120.31% | -40.49% | 48.91% | |
| Enterprise Value | 255 | 165 | 316 | 247 | 95 | 159 | |
| Last Close Price | 7.55 | 6.32 | 11.22 | 9.60 | 4.40 | 7.45 | |
| Forward PE | 15.62 | - | 90.85 | - | - | 8.87 | |
| PS Ratio | 5.36 | 3.65 | 14.25 | 164.24 | - | 1131.07 | |
| PB Ratio | - | -29.57 | -26.06 | -98.13 | 7.26 | 6.61 | |
| P/TBV Ratio | - | - | - | - | 7.26 | 6.61 | |
| P/OCF Ratio | - | 6.44 | - | - | - | - | |
| EV/Sales Ratio | 6.58 | 3.48 | 14.88 | 160.94 | - | 935.98 | |
| EV/EBITDA Ratio | - | 45.94 | - | - | - | - | |
| EV/EBIT Ratio | - | 64.41 | - | - | - | - | |
| Debt / Equity Ratio | -4.31 | -3.29 | -2.66 | -9.69 | 0.32 | - | |
| Debt / EBITDA Ratio | - | 5.37 | - | - | - | - | |
| Asset Turnover | 0.72 | 1.32 | 0.79 | 0.06 | - | 0.01 | |
| Inventory Turnover | 1.48 | 1.98 | 0.92 | - | - | - | |
| Quick Ratio | 4.21 | 5.71 | 2.92 | 5.49 | 12.76 | 12.93 | |
| Current Ratio | 4.69 | 6.38 | 3.56 | 5.80 | 13.54 | 13.39 | |
| Return on Equity (ROE) | - | - | - | -359.22% | -77.36% | -88.45% | |
| Return on Assets (ROA) | -5.39% | 4.47% | -29.67% | -57.21% | -39.99% | -49.07% | |
| Return on Capital (ROIC) | -13.94% | 9.79% | -38.32% | -65.53% | -43.20% | -54.60% | |
| Return on Capital Employed (ROCE) | -11.80% | 6.80% | -66.10% | -101.20% | -83.00% | -61.50% | |
| Earnings Yield | -2.69% | -0.25% | -5.30% | -9.41% | -15.16% | -9.42% | |
| Buyback Yield / Dilution | -1.25% | -2.71% | -1.14% | -1.03% | -9.71% | -19.14% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.